Swathi V. Iyer

Swathi V. Iyer

Auto-generated profile, based on publicly available information

Swathi V. Iyer

Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2016 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
APAlejandro Parrales
Alejandro Parrales
ARAtul Ranjan
Atul Ranjan
SISwathi V. Iyer
Swathi V. Iyer
SPSubhash Padhye
Subhash Padhye
SWScott J. Weir
Scott J. Weir
TITomoo Iwakuma
Tomoo Iwakuma

20 November 2024 in Nature
Verified
Journal Article
Closed access
PDF file
YCYu-Jung Chen
Yu-Jung Chen
SISwathi V. Iyer
Swathi V. Iyer
DHDavid Chun-Cheng Hsieh
David Chun-Cheng Hsieh
BLBuren Li
Buren Li
HEHarold K. Elias
Harold K. Elias
LPLuis F. Parada
Luis F. Parada

16 December 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
SISwathi V. Iyer
Swathi V. Iyer
APAlejandro Parrales
Alejandro Parrales
PBPriya Begani
Priya Begani
ANAkshay Narkar
Akshay Narkar
AAAmit S. Adhikari
Amit S. Adhikari
TITomoo Iwakuma
Tomoo Iwakuma
Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities

25 November 2016 in Nature Communications
Verified
Journal Article
Open access
SISwathi V. Iyer
Swathi V. Iyer
ARAtul Ranjan
Atul Ranjan
HEHarold K. Elias
Harold K. Elias
APAlejandro Parrales
Alejandro Parrales
HSHiromi Sasaki
Hiromi Sasaki
TITomoo Iwakuma
Tomoo Iwakuma
The ability of cancer cells to survive and grow in anchorage- and serum-independent conditions is well correlated with their aggressiveness. Here, using a human whole-genome shRNA library, we identify TMIGD3 isoform1 (i1) as a factor that suppresses this ability in osteosarcoma (OS) cells, mainly by inhibiting NF-κB activity. Knockdown of TMIGD3 increases proliferation, tumour formation and metastasis of OS cells. Overexpression of TMIGD3 isoform1 (i1), but not isoform3 (i3) which shares a common C-terminal region, suppresses these malignant properties. Adenosine A3 receptor (A3AR) having an identical N-terminal region shows similar biological profiles to TMIGD3 i1. Protein expression of TMIGD3 and A3AR is lower in human OS tissues than normal tissues. Mechanistically, TMIGD3 i1 and A3AR commonly inhibit the PKA−Akt−NF-κB axis. However, TMIGD3 i1 only partially rescues phenotypes induced by A3AR knockdown, suggesting the presence of distinct pathways. Our findings reveal an unappreciated role for TMIGD3 i1 as a suppressor of NF-κB activity and OS progression.

20 April 2018 in Oncotarget
Verified
Journal Article
Open access
PDF file
ARAtul Ranjan
Atul Ranjan
SISwathi V. Iyer
Swathi V. Iyer
CWChristopher Ward
Christopher Ward
TLTim Link
Tim Link
FDFrancisco J. Diaz
Francisco J. Diaz
TITomoo Iwakuma
Tomoo Iwakuma
MTBP inhibits the Erk1/2-Elk-1 signaling in hepatocellular carcinoma MTBP inhibits the Erk1/2-Elk-1 signaling in hepatocellular carcinoma

1 October 2015 in Analytical Biochemistry
Verified
Journal Article
Closed access
HSHiromi Sasaki
Hiromi Sasaki
SISwathi V. Iyer
Swathi V. Iyer
KSKen Sasaki
Ken Sasaki
OTOssama W. Tawfik
Ossama W. Tawfik
TITomoo Iwakuma
Tomoo Iwakuma